PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond.

MLA

Saber, Sameh, et al. “PU-H71 (NSC 750424): A Molecular Masterpiece That Targets HSP90 in Cancer and Beyond.” Frontiers in Pharmacology, Nov. 2024, pp. 1–27. EBSCOhost, https://doi.org/10.3389/fphar.2024.1475998.

APA

Saber, S., Abdelhady, R., Elhemely, M. A., Elmorsy, E. A., Hamad, R. S., Abdel-Reheim, M. A., El-kott, A. F., AlShehri, M. A., Morsy, K., AlSheri, A. S., & Youssef, M. E. (2024). PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond. Frontiers in Pharmacology, 1–27. https://doi.org/10.3389/fphar.2024.1475998

Chicago

Saber, Sameh, Rasha Abdelhady, Mai A. Elhemely, Elsayed A. Elmorsy, Rabab S. Hamad, Mustafa Ahmed Abdel-Reheim, Attalla F. El-kott, et al. 2024. “PU-H71 (NSC 750424): A Molecular Masterpiece That Targets HSP90 in Cancer and Beyond.” Frontiers in Pharmacology, November, 1–27. doi:10.3389/fphar.2024.1475998.